Cargando…
Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study
BACKGROUND: Men with germline breast cancer 1, early onset (BRCA1) or breast cancer 2, early onset (BRCA2) gene mutations have a higher risk of developing prostate cancer (PCa) than noncarriers. IMPACT (Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in BRC...
Ejemplares similares
-
Virtual Conferences and the COVID-19 Pandemic: Are We Missing Out with an Online Only Platform?
por: Woodruff, Phillip, et al.
Publicado: (2021) -
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
por: Page, Elizabeth C., et al.
Publicado: (2019) -
The Emerging Role of Artificial Intelligence in the Fight Against COVID-19
por: Ghose, Aruni, et al.
Publicado: (2020) -
Traditional and Virtual Congress Meetings During the COVID-19 Pandemic and the Post-COVID-19 Era: Is it Time to Change the Paradigm?
por: Porpiglia, Francesco, et al.
Publicado: (2020) -
Urolithiasis in the COVID Era: An Opportunity to Reassess Management Strategies
por: Steinberg, Ryan L., et al.
Publicado: (2020)